MSCI Interest Paid increased by 53.1% to $79.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 135.1%, from $33.60M to $79.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 3.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $57.75M | $24.56M | $49.70M | $27.78M | $50.41M | $28.98M | $57.95M | $33.80M | $56.86M | $34.41M | $57.25M | $34.05M | $56.68M | $34.23M | $54.99M | $33.60M | $56.08M | $32.04M | $51.59M | $79.00M |
| QoQ Change | — | -57.5% | +102.4% | -44.1% | +81.5% | -42.5% | +100.0% | -41.7% | +68.2% | -39.5% | +66.4% | -40.5% | +66.5% | -39.6% | +60.6% | -38.9% | +66.9% | -42.9% | +61.0% | +53.1% |
| YoY Change | — | — | — | — | -12.7% | +18.0% | +16.6% | +21.7% | +12.8% | +18.7% | -1.2% | +0.7% | -0.3% | -0.5% | -3.9% | -1.3% | -1.1% | -6.4% | -6.2% | +135.1% |